Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
2018
282 citations
Journal Article
gold Open Access
Field-Weighted Citation Impact:
9.25
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial | Researchclopedia
·
AstraZeneca (Singapore)
Anas Younes
·
Memorial Sloan Kettering Cancer Center
John Nemunaitis
·
Mary Crowley Cancer Research Center
Nathan Fowler
·
The University of Texas MD Anderson Cancer Center
Michael A. Curran
·
The University of Texas MD Anderson Cancer Center
Qinying Liu
·
The University of Texas MD Anderson Cancer Center
Tianyuan Zhou
·
Ionis Pharmaceuticals (United States)
Joanna Schmidt
·
Ionis Pharmaceuticals (United States)
Minji Jo
·
Ionis Pharmaceuticals (United States)
Samantha J. Lee
·
Ionis Pharmaceuticals (United States)
Mason Yamashita
·
Ionis Pharmaceuticals (United States)
Steven G. Hughes
·
Ionis Pharmaceuticals (United States)
Luis Fayad
·
The University of Texas MD Anderson Cancer Center
Sarina A. Piha‐Paul
·
The University of Texas MD Anderson Cancer Center
Murali V.P. Nadella
·
AstraZeneca (Singapore)
Xiaokun Xiao
·
Ionis Pharmaceuticals (United States)
Jeff Hsu
·
Ionis Pharmaceuticals (United States)
Alexey S. Revenko
·
Ionis Pharmaceuticals (United States)
Brett P. Monia
·
Ionis Pharmaceuticals (United States)
A. Robert MacLeod
·
Ionis Pharmaceuticals (United States)
David S. Hong
·
The University of Texas MD Anderson Cancer Center